Abbott Laboratories (ABT) earnings

Earnings (net income) · fiscal 2025
$6.52B

Abbott Laboratories (ABT) reported net income of $6.52B in fiscal 2025 (the year ended December 31, 2025). That is 51.3% lower than the $13.40B of fiscal 2024. Figures as of 18 Nov 2026, 04:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$6.52B
Change on fiscal 2024
−51.3%
Growth, 5 years
+7.7% a year
Growth, 10 years
+4.0% a year
Highest on record
$13.40Bfiscal 2024
Lowest on record
$477.00Mfiscal 2017
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Abbott Laboratories earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 7.7% a year; over ten years the rate was 4.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $13.40B in fiscal 2024 and the lowest $477.00M in fiscal 2017.

History · 19 fiscal years

Earnings (net income) by fiscal year

Abbott Laboratories earnings, year by year

Abbott Laboratories (ABT) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$6.52B 51.3% down
2024$13.40B 134.2% up
2023$5.72B 17.5% down
2022$6.93B 2.0% down
2021$7.07B 57.3% up
2020$4.50B 21.9% up
2019$3.69B 55.7% up
2018$2.37B 396.4% up
2017$477.00M 65.9% down
2016$1.40B 68.3% down
2015$4.42B 93.7% up
2014$2.28B 11.3% down
2013$2.58B 56.8% down
2012$5.96B 26.1% up
2011$4.73B 2.2% up
2010$4.63B 19.5% down
2009$5.75B 17.7% up
2008$4.88B 35.3% up
2007$3.61B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Abbott Laboratories and comparable companies
CompanyEarnings (net income)Fiscal year
Gilead Sciences GILD$8.51B2025
Abbott Laboratories ABT$6.52B2025
Novo Nordisk NVODKK 102.43B2025
Pfizer PFE$7.77B2025
Danaher DHR$3.61B2025
Intuitive Surgical ISRG$2.86B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABT

Abbott Laboratories, figure by figure

Abbott Laboratories (ABT) overview: price, valuation and scorecardAll health care companies by market value

Abbott Laboratories earnings: questions and answers

What is Abbott Laboratories's net income?

Abbott Laboratories (ABT) reported net income of $6.52B in fiscal 2025 (the year ended December 31, 2025). That is 51.3% lower than the $13.40B of fiscal 2024.

What is the growth rate of Abbott Laboratories's net income?

Over the five fiscal years to 2025 net income grew at a compound 7.7% a year; over ten years the rate was 4.0% a year.

What are the highest and lowest net income figures on record for Abbott Laboratories?

Across the 19 fiscal years on record (2007–2025), the highest was $13.40B in fiscal 2024 and the lowest $477.00M in fiscal 2017.

How is Abbott Laboratories's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.